NAVA (Navamedic ASA) vs Oslo OBX Comparison

NAVA

Oslo OBX

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

NAVA

Oslo OBX

Difference

1Y 3Y 5Y 10Y 15Y 20Y

NAVA

Oslo OBX

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Oslo OBX

NAVA

LLY

DPH

NOVO B

JNJ

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Navamedic ASA
Glance View

Market Cap

423.6m NOK

Industry

Pharmaceuticals

Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The firm in-licenses, acquires and markets pharmaceuticals and other healthcare products in northern Europe. The product portfolio includes original and generic pharmaceuticals, as well as food supplements, medical devices and other healthcare products. Navamedic ASA has three subsidiaries: Observe Medical, a Swedish medical technology company; Vitaflo Scandinavia AB, which focuses on in-licensing and buying pharmaceuticals and other healthcare products within a few selected knowledge areas; and Navamedic ehf, which builds its business around the sales and marketing of generic pharmaceuticals targeted towards the Nordic and BeNeLux markets. The Navamedic business unit is built upon the cooperation with the South African pharmaceutical company Aspen Healthcare. The Company’s largest shareholder is Nobelsystem Scandinavia.

View NAVA Analysis

NAVA Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Add
US		Eli Lilly and Co NYSE:LLY	Add
UK		Dechra Pharmaceuticals PLC LSE:DPH	Add
DK		Novo Nordisk A/S CSE:NOVO B	Add
US		Johnson & Johnson NYSE:JNJ	Add
US		Merck & Co Inc NYSE:MRK	Add
CH		Roche Holding AG SIX:ROG	Add
UK		AstraZeneca PLC LSE:AZN	Add
CH		Novartis AG SIX:NOVN	Add
US		Pfizer Inc NYSE:PFE	Add

JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Select
US		Eli Lilly and Co NYSE:LLY	Select
UK		Dechra Pharmaceuticals PLC LSE:DPH	Select
DK		Novo Nordisk A/S CSE:NOVO B	Select
US		Johnson & Johnson NYSE:JNJ	Select
US		Merck & Co Inc NYSE:MRK	Select
CH		Roche Holding AG SIX:ROG	Select
UK		AstraZeneca PLC LSE:AZN	Select
CH		Novartis AG SIX:NOVN	Select
US		Pfizer Inc NYSE:PFE	Select

JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Add
US		Eli Lilly and Co NYSE:LLY	Add
UK		Dechra Pharmaceuticals PLC LSE:DPH	Add
DK		Novo Nordisk A/S CSE:NOVO B	Add
US		Johnson & Johnson NYSE:JNJ	Add
US		Merck & Co Inc NYSE:MRK	Add
CH		Roche Holding AG SIX:ROG	Add
UK		AstraZeneca PLC LSE:AZN	Add
CH		Novartis AG SIX:NOVN	Add
US		Pfizer Inc NYSE:PFE	Add

HR	C	CROBEX INDX:CRBEX	Add
SA	T	Tadawul All Share INDX:TASI	Add
TH	S	SET Index INDX:SET	Add
ID	J	Jakarta Composite Index INDX:JKSE	Add
GR	A	Athens General Composite INDX:ATG	Add
BR	B	BOVESPA INDX:BVSP	Add
AR	S	S&P Merval INDX:MERV	Add
MX	M	Mexico S&P/BMV IPC INDX:MXX	Add
CZ	P	PX Prague Stock Index INDX:PX	Add
RU	M	MOEX Russia INDX:IMOEX	Add

	Franklin Covey Co NYSE:FC	31.6 USD -10.48%
	Mohawk Industries Inc NYSE:MHK	118.12 USD -0.14%
	Ardmore Shipping Corp NYSE:ASC	13.57 USD 8.04%
	ASGN Inc NYSE:ASGN	85.435 USD -1.71%
	Skyworks Solutions Inc NASDAQ:SWKS	93.68 USD 1.13%
	Weatherford International PLC NASDAQ:WFRD	72.135 USD 0.01%

NAVA

vs

Oslo OBX

Stocks Performance
NAVA vs Oslo OBX

Performance Gap
NAVA vs Oslo OBX

Performance By Year
NAVA vs Oslo OBX

Competitors Performance
Navamedic ASA vs Peers

Navamedic ASA
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	142.52 USD 0.18%
	Bank of America Corp NYSE:BAC	45.1 USD -2.4%
	Mastercard Inc NYSE:MA	507 USD -1.82%
	Salesforce Inc NYSE:CRM	319.06 USD -2.4%
	Abbvie Inc NYSE:ABBV	176.24 USD -1.27%
	Home Depot Inc NYSE:HD	390.19 USD 0.77%

	Arista Networks Inc NYSE:ANET	114.38 USD -0.98%
	Visa Inc NYSE:V	308.445 USD -1.33%
	Texas Pacific Land Corp NYSE:TPL	1 296.72 USD 1.63%
	KLA Corp NASDAQ:KLAC	693.255 USD 1.03%
	Manhattan Associates Inc NASDAQ:MANH	267.64 USD -1.78%
	Pinduoduo Inc NASDAQ:PDD	95.84 USD -4.47%

	Salesforce Inc NYSE:CRM	319.06 USD -2.4%
	ServiceNow Inc NYSE:NOW	1 031.01 USD -1.72%
	EOG Resources Inc NYSE:EOG	131.45 USD 2.33%
	Copart Inc NASDAQ:CPRT	55.77 USD -1.78%
	Applied Materials Inc NASDAQ:AMAT	172.88 USD -2.32%
	Synopsys Inc NASDAQ:SNPS	493.59 USD -1.68%

	Johnson & Johnson NYSE:JNJ	142.52 USD 0.18%
	Berkshire Hathaway Inc NYSE:BRK.A	665 919.755 USD -1.77%
	Bank of America Corp NYSE:BAC	45.1 USD -2.4%
	Mastercard Inc NYSE:MA	507 USD -1.82%
	UnitedHealth Group Inc NYSE:UNH	528.21 USD 0.7%
	Exxon Mobil Corp NYSE:XOM	106.96 USD 0.03%

NAVA vs Oslo OBX

Stocks Performance NAVA vs Oslo OBX

Performance Gap NAVA vs Oslo OBX

Performance By Year NAVA vs Oslo OBX

Competitors Performance Navamedic ASA vs Peers

Navamedic ASA Glance View

Company

Help

Tools

Stocks

NAVA

vs

Oslo OBX

Stocks Performance
NAVA vs Oslo OBX

Performance Gap
NAVA vs Oslo OBX

Performance By Year
NAVA vs Oslo OBX

Competitors Performance
Navamedic ASA vs Peers

Navamedic ASA
Glance View